CN110248654A - 包含铜-羟基吡喃酮络合物的抗微生物组合物 - Google Patents

包含铜-羟基吡喃酮络合物的抗微生物组合物 Download PDF

Info

Publication number
CN110248654A
CN110248654A CN201880010474.0A CN201880010474A CN110248654A CN 110248654 A CN110248654 A CN 110248654A CN 201880010474 A CN201880010474 A CN 201880010474A CN 110248654 A CN110248654 A CN 110248654A
Authority
CN
China
Prior art keywords
composition
copper
treatment
antibacterial
antibacterial composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880010474.0A
Other languages
English (en)
Chinese (zh)
Inventor
乔纳森·约瑟夫·鲍威尔
努诺·乔治·罗德里格斯·法里亚
卡洛斯·安德烈·帕索斯·巴斯托斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
British Research And Innovation Agency
Original Assignee
British Research And Innovation Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Research And Innovation Agency filed Critical British Research And Innovation Agency
Publication of CN110248654A publication Critical patent/CN110248654A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201880010474.0A 2017-02-06 2018-02-06 包含铜-羟基吡喃酮络合物的抗微生物组合物 Pending CN110248654A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1701944.9 2017-02-06
GBGB1701944.9A GB201701944D0 (en) 2017-02-06 2017-02-06 Antimicrobial compositions and their uses
PCT/EP2018/052958 WO2018141989A1 (en) 2017-02-06 2018-02-06 Antimicrobial compositions comprising copper-hydroxypyrone complexes

Publications (1)

Publication Number Publication Date
CN110248654A true CN110248654A (zh) 2019-09-17

Family

ID=58462497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880010474.0A Pending CN110248654A (zh) 2017-02-06 2018-02-06 包含铜-羟基吡喃酮络合物的抗微生物组合物

Country Status (10)

Country Link
US (1) US11000502B2 (enExample)
EP (1) EP3576730A1 (enExample)
JP (1) JP2020506201A (enExample)
CN (1) CN110248654A (enExample)
AU (1) AU2018216241A1 (enExample)
BR (1) BR112019016189A2 (enExample)
CA (1) CA3051519A1 (enExample)
GB (1) GB201701944D0 (enExample)
SG (1) SG11201906781VA (enExample)
WO (1) WO2018141989A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220175602A1 (en) * 2019-12-02 2022-06-09 Halcyon Inc. Bedsore-preventing mattress combined with sound vibration module and air fibers, and operating method therefor
CN111647533A (zh) * 2020-06-16 2020-09-11 科里思特(福建)生物科技有限公司 一种枯草芽孢杆菌及其制剂与应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315851A (zh) * 1998-09-23 2001-10-03 荷兰联合利华有限公司 口腔护理组合物
JP2002255956A (ja) * 2001-02-27 2002-09-11 Sumitomo Chem Co Ltd 防カビ剤
JP2009256228A (ja) * 2008-04-15 2009-11-05 Lion Corp 液体口腔用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138155A (ja) * 1993-11-12 1995-05-30 Otsuka Pharmaceut Co Ltd 抗微生物剤
GB9621273D0 (en) * 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
US6505233B1 (en) 1999-08-30 2003-01-07 Zaplet, Inc. Method for communicating information among a group of participants
GB201402672D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315851A (zh) * 1998-09-23 2001-10-03 荷兰联合利华有限公司 口腔护理组合物
JP2002255956A (ja) * 2001-02-27 2002-09-11 Sumitomo Chem Co Ltd 防カビ剤
JP2009256228A (ja) * 2008-04-15 2009-11-05 Lion Corp 液体口腔用組成物

Also Published As

Publication number Publication date
WO2018141989A1 (en) 2018-08-09
SG11201906781VA (en) 2019-08-27
AU2018216241A1 (en) 2019-08-29
BR112019016189A2 (pt) 2020-04-14
JP2020506201A (ja) 2020-02-27
US11000502B2 (en) 2021-05-11
US20190380996A1 (en) 2019-12-19
GB201701944D0 (en) 2017-03-22
CA3051519A1 (en) 2018-08-09
EP3576730A1 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
JP6775523B2 (ja) オキソ水酸化銅ナノ粒子を含む抗細菌組成物およびそれらの殺生物剤としての使用
CN103566371B (zh) 抗微生物的物理方法
US20100068297A1 (en) Antimicrobial Composition
RU2553363C2 (ru) Антисептические композиции и их применения
US20250114398A1 (en) Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereof
CN101411898A (zh) 一种有机/无机复合抗菌导尿管及其制备方法
JP2010531320A (ja) 治療薬または消毒薬としての相乗的組成物の使用
US11000502B2 (en) Antimicrobial compositions comprising copper-hydroxypyrone complexes
CN103249419A (zh) 具有抗菌和创伤愈合活性的组合物
Spear Silver: an age-old treatment modality in modern times
JOUDAH et al. Topical mupirocin-steroid for wound care in an era of rising antibiotic resistance
CN101766650B (zh) 手术冲洗液及其制备方法
CN109512692B (zh) 一种湿巾抗菌添加液及其制备方法
Tiwari et al. Silver Dressings Revisited
HK1245642B (en) Antibacterial compositions comprising copper oxo-hydroxide nanoparticles and their preparation
Mirabeau et al. Antimicrobial potentials of silver colloidal (nanorods) on clinical isolates in Bayelsa state, Nigeria
RO134540A2 (ro) Sisteme antimicrobiene care conţin nanoparticule de argint şi antibiotic pentru aplicaţii biomedicale: preparare şi caracterizare
Low Lipsome encapsulated antimicrobial metal ions and essential oils
HK1217648B (zh) 抗微生物的物理方法
CZ23952U1 (cs) Kombinovaný farmaceutický přípravek, zejména s antibakteriálním a fungicidním účinkem

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190917

WD01 Invention patent application deemed withdrawn after publication